Issn Print: 1556-0864
Publication Date: 2017/07/01
Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib TargetingMETAmplification Sequentially Emerging after T790M Positivity inEGFR-Mutant Non–Small Cell Lung Cancer
Emily R. York; Marileila Varella-Garcia; Tami J. Bang; Dara L. Aisner; Ross D. Camidge
Author Information: Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.